Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis
This study has been completed.
Study NCT00917020   Information provided by Capnia, Inc.

First Received on June 8, 2009.   Last Updated on August 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Seasonal Allergic Rhinitis
Additional conditions recognized in this trial
Rhinitis
Rhinitis, Allergic, Seasonal
More general conditions related to this trial
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Nasal CO2
Inactive Placebo Gas
Sponsors listed in this trial
Capnia, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services